The regulation of body mass and its relation to the development of obesity
Sndergaard CS, Esquivel PN, Dalamaga M, Magkos F
doi:10.1002/biof.5520190309 Grtner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW
Optimized Protocol for Selective Fat Metabolism Dosing: Starting dose: 250 mcg per day (subcutaneous injection) Standard dose: 300-500 mcg per day after 1-2 weeks Frequency: Once daily or divided into two doses (morning and early afternoon) Administration: Route: Subcutaneous injection (abdomen, thigh, or upper arm) Timing: Morning fasted state ideal, or 30-60 minutes before cardio Storage: Reconstituted peptide refrigerated, typically stable 30-60 days Cycle Length: 12-16 weeks for initial assessment, with potential for extended protocols based on clinical trial data showing safe use up to 24 weeks
Those With Certain Eye Conditions For some patients with diabetes, semaglutide can worsen diabetic retinopathy, a serious complication that affects the blood vessels of the eye